47OPhase 1 study of bispecific HER2 antibody-drug conjugate MEDI4276 in patients with advanced HER2-positive breast or gastric cancer. (5th March 2018) - Pegram, M; Hamilton, E; Tan, A R; Storniolo, A M; Elgeioushi, N; Marshall, S; Abdullah, S; Patel, M